217 related articles for article (PubMed ID: 10645473)
1. Recent advances in Canavan disease.
Matalon R; Michals-Matalon K
Adv Pediatr; 1999; 46():493-506. PubMed ID: 10645473
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of Canavan disease.
Matalon R; Michals-Matalon K
Eur J Paediatr Neurol; 1998; 2(2):69-76. PubMed ID: 10724099
[No Abstract] [Full Text] [Related]
3. Canavan disease: a review of recent developments.
Gordon N
Eur J Paediatr Neurol; 2001; 5(2):65-9. PubMed ID: 11589315
[TBL] [Abstract][Full Text] [Related]
4. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system.
Matalon R; Rady PL; Platt KA; Skinner HB; Quast MJ; Campbell GA; Matalon K; Ceci JD; Tyring SK; Nehls M; Surendran S; Wei J; Ezell EL; Szucs S
J Gene Med; 2000; 2(3):165-75. PubMed ID: 10894262
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry and molecular biology of Canavan disease.
Matalon R; Michals-Matalon K
Neurochem Res; 1999 Apr; 24(4):507-13. PubMed ID: 10227683
[TBL] [Abstract][Full Text] [Related]
6. Canavan disease: diagnosis and molecular analysis.
Matalon R
Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621
[TBL] [Abstract][Full Text] [Related]
7. Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan's disease.
Velinov M; Zellers N; Styles J; Wisniewski K
Clin Genet; 2008 Mar; 73(3):288-9. PubMed ID: 18070137
[No Abstract] [Full Text] [Related]
8. Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
Rady PL; Penzien JM; Vargas T; Tyring SK; Matalon R
Eur J Paediatr Neurol; 2000; 4(1):27-30. PubMed ID: 10701101
[TBL] [Abstract][Full Text] [Related]
9. Canavan disease: from spongy degeneration to molecular analysis.
Matalon R; Michals K; Kaul R
J Pediatr; 1995 Oct; 127(4):511-7. PubMed ID: 7562269
[TBL] [Abstract][Full Text] [Related]
10. Possible genotype-phenotype correlations in children with mild clinical course of Canavan disease.
Tacke U; Olbrich H; Sass JO; Fekete A; Horvath J; Ziyeh S; Kleijer WJ; Rolland MO; Fisher S; Payne S; Vargiami E; Zafeiriou DI; Omran H
Neuropediatrics; 2005 Aug; 36(4):252-5. PubMed ID: 16138249
[TBL] [Abstract][Full Text] [Related]
11. Novel mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
Unalp A; Altiok E; Uran N; Oztürk A; Yüksel S
J Trop Pediatr; 2008 Jun; 54(3):208-10. PubMed ID: 17999961
[TBL] [Abstract][Full Text] [Related]
12. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ
Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
[TBL] [Abstract][Full Text] [Related]
13. Atypical MRI findings in Canavan disease: a patient with a mild course.
Yalcinkaya C; Benbir G; Salomons GS; Karaarslan E; Rolland MO; Jakobs C; van der Knaap MS
Neuropediatrics; 2005 Oct; 36(5):336-9. PubMed ID: 16217711
[TBL] [Abstract][Full Text] [Related]
14. [Canavan disease or N-acetyl aspartic aciduria: a case report].
Boughamoura L; Chaabane F; Tilouche S; Chabchoub I; Kabachi N; Tlili K; Yacoub M; Essoussi AS
Arch Pediatr; 2007 Feb; 14(2):173-6. PubMed ID: 17196380
[TBL] [Abstract][Full Text] [Related]
15. A mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
Eke GH; Iscan A; Cece H; Calik M
Genet Couns; 2012; 23(1):9-12. PubMed ID: 22611636
[TBL] [Abstract][Full Text] [Related]
16. [Canavan disease].
Harting I; Seitz A
Rofo; 2001 Oct; 173(10):M275-6. PubMed ID: 11710318
[No Abstract] [Full Text] [Related]
17. Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene.
Janson CG; Kolodny EH; Zeng BJ; Raghavan S; Pastores G; Torres P; Assadi M; McPhee S; Goldfarb O; Saslow B; Freese A; Wang DJ; Bilaniuk L; Shera D; Leone P
Ann Neurol; 2006 Feb; 59(2):428-31. PubMed ID: 16437572
[TBL] [Abstract][Full Text] [Related]
18. New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion.
Di Pietro V; Cavallari U; Amorini AM; Lazzarino G; Longo S; Poggiani C; Cavalli P; Tavazzi B
Clin Biochem; 2013 Dec; 46(18):1902-4. PubMed ID: 24036223
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of Canavan disease--problems and dilemmas.
Besley GT; Elpeleg ON; Shaag A; Manning NJ; Jakobs C; Walter JH
J Inherit Metab Dis; 1999 May; 22(3):263-6. PubMed ID: 10384383
[No Abstract] [Full Text] [Related]
20. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M
Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
